DXR
Price
$11.06
Change
-$0.27 (-2.38%)
Updated
Sep 5 closing price
Capitalization
55.13M
IART
Price
$15.99
Change
+$0.34 (+2.17%)
Updated
Sep 5 closing price
Capitalization
1.25B
53 days until earnings call
Interact to see
Advertisement

DXR vs IART

Header iconDXR vs IART Comparison
Open Charts DXR vs IARTBanner chart's image
Daxor
Price$11.06
Change-$0.27 (-2.38%)
Volume$12.86K
Capitalization55.13M
Integra LifeSciences Holdings
Price$15.99
Change+$0.34 (+2.17%)
Volume$1.2M
Capitalization1.25B
DXR vs IART Comparison Chart in %
Loading...
DXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IART
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DXR vs. IART commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DXR is a Hold and IART is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (DXR: $11.06 vs. IART: $15.99)
Brand notoriety: DXR and IART are both not notable
DXR represents the Pharmaceuticals: Other, while IART is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: DXR: 34% vs. IART: 96%
Market capitalization -- DXR: $55.13M vs. IART: $1.25B
DXR [@Pharmaceuticals: Other] is valued at $55.13M. IART’s [@Medical/Nursing Services] market capitalization is $1.25B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $162.93B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.38B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.04B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DXR’s FA Score shows that 1 FA rating(s) are green whileIART’s FA Score has 1 green FA rating(s).

  • DXR’s FA Score: 1 green, 4 red.
  • IART’s FA Score: 1 green, 4 red.
According to our system of comparison, DXR is a better buy in the long-term than IART.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DXR’s TA Score shows that 3 TA indicator(s) are bullish while IART’s TA Score has 4 bullish TA indicator(s).

  • DXR’s TA Score: 3 bullish, 5 bearish.
  • IART’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IART is a better buy in the short-term than DXR.

Price Growth

DXR (@Pharmaceuticals: Other) experienced а +0.55% price change this week, while IART (@Medical/Nursing Services) price change was +5.68% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.24%. For the same industry, the average monthly price growth was +7.04%, and the average quarterly price growth was +16.54%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.04%. For the same industry, the average monthly price growth was +4.21%, and the average quarterly price growth was +24.44%.

Reported Earning Dates

IART is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.24% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-0.04% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IART($1.25B) has a higher market cap than DXR($55.1M). DXR (69.13) and IART (66.48) have similar P/E ratio . DXR YTD gains are higher at: 43.823 vs. IART (-29.497). DXR has less debt than IART: DXR (730K) vs IART (2.01B). IART has higher revenues than DXR: IART (1.62B) vs DXR (2.13M).
DXRIARTDXR / IART
Capitalization55.1M1.25B4%
EBITDAN/A-332.17M-
Gain YTD43.823-29.497-149%
P/E Ratio69.1366.48104%
Revenue2.13M1.62B0%
Total CashN/A254M-
Total Debt730K2.01B0%
FUNDAMENTALS RATINGS
DXR vs IART: Fundamental Ratings
DXR
IART
OUTLOOK RATING
1..100
9316
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
80
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9097
PRICE GROWTH RATING
1..100
4152
P/E GROWTH RATING
1..100
29
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IART's Valuation (80) in the Medical Specialties industry is in the same range as DXR (90). This means that IART’s stock grew similarly to DXR’s over the last 12 months.

IART's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as DXR (100). This means that IART’s stock grew similarly to DXR’s over the last 12 months.

DXR's SMR Rating (90) in the Medical Specialties industry is in the same range as IART (97). This means that DXR’s stock grew similarly to IART’s over the last 12 months.

DXR's Price Growth Rating (41) in the Medical Specialties industry is in the same range as IART (52). This means that DXR’s stock grew similarly to IART’s over the last 12 months.

DXR's P/E Growth Rating (2) in the Medical Specialties industry is in the same range as IART (9). This means that DXR’s stock grew similarly to IART’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DXRIART
RSI
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
68%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
75%
Momentum
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
63%
MACD
ODDS (%)
Bearish Trend 1 day ago
71%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
71%
Bullish Trend 1 day ago
61%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
58%
Advances
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 1 day ago
60%
Declines
ODDS (%)
Bearish Trend 4 days ago
74%
Bearish Trend 16 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 1 day ago
79%
Aroon
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
57%
View a ticker or compare two or three
Interact to see
Advertisement
DXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IART
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMNNY11.380.06
+0.53%
Shimano Inc.
AUUMF13.80N/A
N/A
Aumann AG
FRCEF1.90N/A
N/A
Fletcher Building Ltd.
AILIM77.75N/A
N/A
Ameren Illinois Company
ECLP6.10N/A
N/A
Eclipse Bancorp Inc.

DXR and

Correlation & Price change

A.I.dvisor tells us that DXR and IART have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DXR and IART's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DXR
1D Price
Change %
DXR100%
-2.38%
IART - DXR
33%
Poorly correlated
+2.17%
BWAY - DXR
27%
Poorly correlated
-0.75%
NOTV - DXR
24%
Poorly correlated
+2.50%
QIPT - DXR
23%
Poorly correlated
-0.38%
COO - DXR
20%
Poorly correlated
+0.13%
More

IART and

Correlation & Price change

A.I.dvisor indicates that over the last year, IART has been loosely correlated with ENOV. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if IART jumps, then ENOV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IART
1D Price
Change %
IART100%
+2.17%
ENOV - IART
59%
Loosely correlated
+1.84%
ITGR - IART
53%
Loosely correlated
+0.32%
CNMD - IART
52%
Loosely correlated
+0.51%
RVTY - IART
49%
Loosely correlated
+1.10%
ZBH - IART
48%
Loosely correlated
+0.93%
More